{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T04:55:56Z","timestamp":1769748956332,"version":"3.49.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"E-Rare-2"},{"DOI":"10.13039\/100010661","name":"European Union Horizon 2020 research","doi-asserted-by":"publisher","award":["667837"],"award-info":[{"award-number":["667837"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002129","name":"Heart Foundation Netherlands","doi-asserted-by":"publisher","award":["310372"],"award-info":[{"award-number":["310372"]}],"id":[{"id":"10.13039\/100002129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81501727"],"award-info":[{"award-number":["81501727"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10,19]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Signal transducer and activator of transcription 1 (STAT-1) gain-of-function (GOF) mutations cause chronic mucocutaneous candidiasis (CMC), a disease associated with Candida albicans and Staphylococcus aureus infection. Patients suffer from dysegulated immune responses due to aberrant cell programming and function. We investigated the effect of inhibitory molecules targeting histone deacetylases (HDACi) on the immune responses of peripheral blood mononuclear cells (PBMCs) of healthy controls and patients with CMC towards microbes relevant for CMC. PBMCs cells were pretreated with HDACi and challenged with C. albicans or S. aureus. Innate and adaptive cytokines were measured in cell culture supernatants by enzyme-linked immunosorbent assay (ELISA). We assessed the effect of HDAC inhibitors on T helper type 1 (Th1) and Th17 cells and measured STAT-1 and STAT-3 phosphorylation using flow cytometry. Panobinostat, a pan-HDAC inhibitor, strongly inhibits innate and adaptive cytokines upon challenge with C. albicans or S. aureus. Specific inhibitors (entinostat or RGFP966) also had a tendency to lower production of most innate cytokines in CMC patient cells. Entinostat and RGFP966 increased the production of interleukin (IL)-22 specifically after S. aureus challenge in patient cells. In healthy and control cells, entinostat and RGFP966 treatment down-regulated STAT-1 phosphorylation while pSTAT-3 levels remained stable. HDACi modulate cytokine production in response to C. albicans and S. aureus. Pan-inhibitors lower overall cytokine production, whereas specific inhibitors confer a selective effect. Entinostat and RGFP966 are promising therapeutic candidates to treat STAT-1 GOF due to their capacity to restore IL-22 production and decrease STAT-1 phosphorylation; however, their inhibition of innate cytokines poses a possible risk to secondary infections.<\/jats:p>","DOI":"10.1111\/cei.13192","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T13:16:42Z","timestamp":1533302202000},"page":"205-219","source":"Crossref","is-referenced-by-count":18,"title":["HDAC inhibitors modulate innate immune responses to micro-organisms relevant to chronic mucocutaneous candidiasis"],"prefix":"10.1093","volume":"194","author":[{"given":"B","family":"R\u00f6sler","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Radboud Center for Infectious diseases (RCI), Radboud UMC, Nijmegen, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Radboud Center for Infectious diseases (RCI), Radboud UMC, Nijmegen, the Netherlands"},{"name":"Department of Dermatology, Peking University First Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S T","family":"Keating","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Radboud Center for Infectious diseases (RCI), Radboud UMC, Nijmegen, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L A B","family":"Joosten","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Radboud Center for Infectious diseases (RCI), Radboud UMC, Nijmegen, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M G","family":"Netea","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Radboud Center for Infectious diseases (RCI), Radboud UMC, Nijmegen, the Netherlands"},{"name":"Department for Genomics and Immunoregulation, Life and Medical Sciences Institute (LIMES), University of Bonn, Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F L","family":"van de Veerdonk","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Radboud Center for Infectious diseases (RCI), Radboud UMC, Nijmegen, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,10,1]]},"reference":[{"key":"2021120808502254900_cei13192-bib-0001","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1038\/cti.2016.71","article-title":"Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity","volume":"5","author":"Okada","year":"2016","journal-title":"Clin Transl Immunology"},{"key":"2021120808502254900_cei13192-bib-0002","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1161\/CIRCRESAHA.116.303936","article-title":"Epigenetics and metabolism","volume":"116","author":"Keating","year":"2015","journal-title":"Circ Res"},{"key":"2021120808502254900_cei13192-bib-0003","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.cellsig.2013.05.007","article-title":"Regulation of STAT signaling by acetylation","volume":"25","author":"Zhuang","year":"2013","journal-title":"Cell Signal"},{"key":"2021120808502254900_cei13192-bib-0004","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1096\/fj.05-5360com","article-title":"LPS regulates proinflammatory gene expression in macrophages by altering histone deacetylase expression","volume":"20","author":"Aung","year":"2006","journal-title":"FASEB J"},{"key":"2021120808502254900_cei13192-bib-0005","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1101\/gad.552310","article-title":"Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression","volume":"24","author":"Yamaguchi","year":"2010","journal-title":"Genes Dev"},{"key":"2021120808502254900_cei13192-bib-0006","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1084\/jem.20042034","article-title":"Phosphorylation of histone deacetylase 7 by protein kinase D mediates T cell receptor-induced Nur77 expression and apoptosis","volume":"201","author":"Dequiedt","year":"2005","journal-title":"J Exp Med"},{"key":"2021120808502254900_cei13192-bib-0007","doi-asserted-by":"crossref","first-page":"757","DOI":"10.7150\/ijbs.9067","article-title":"Targeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implications","volume":"10","author":"Li","year":"2014","journal-title":"Int J Biol Sci"},{"key":"2021120808502254900_cei13192-bib-0008","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-3-319-24738-0_2","article-title":"HIV-induced epigenetic alterations in host cells","volume":"879","author":"Abdel-Hameed","year":"2016","journal-title":"Adv Exp Med Biol"},{"key":"2021120808502254900_cei13192-bib-0009","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/antibiotics4010044","article-title":"Augmentation of cationic antimicrobial peptide production with histone deacetylase inhibitors as a novel epigenetic therapy for bacterial infections","volume":"4","author":"Yedery","year":"2015","journal-title":"Antibiotics (Basel)"},{"key":"2021120808502254900_cei13192-bib-0010","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/j.jinf.2016.04.023","article-title":"Treatment options for chronic mucocutaneous candidiasis","volume":"72","author":"van de Veerdonk","year":"2016","journal-title":"J Infect"},{"key":"2021120808502254900_cei13192-bib-0011","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1002\/eji.201445344","article-title":"Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC)","volume":"45","author":"Zheng","year":"2015","journal-title":"Eur J Immunol"},{"key":"2021120808502254900_cei13192-bib-0012","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/cea.12787","article-title":"Th2 and Th9 responses in patients with chronic mucocutaneous candidiasis and hyper-IgE syndrome","volume":"46","author":"Becker","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"2021120808502254900_cei13192-bib-0013","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1080\/00498254.2016.1184356","article-title":"Clinical pharmacokinetics of panobinostat, a novel histone deacetylase (HDAC) inhibitor: review and perspectives","volume":"47","author":"Srinivas","year":"2017","journal-title":"Xenobiotica"},{"key":"2021120808502254900_cei13192-bib-0014","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1158\/1078-0432.CCR-07-1461","article-title":"A phase I and pharmacokinetic study of the oral histone deacetylase inhibitor, MS-275, in patients with refractory solid tumors and lymphomas","volume":"14","author":"Gore","year":"2008","journal-title":"Clin Cancer Res"},{"key":"2021120808502254900_cei13192-bib-0015","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nri3897","article-title":"Immune defence against Candida fungal infections","volume":"15","author":"Netea","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"2021120808502254900_cei13192-bib-0016","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","article-title":"Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype","volume":"127","author":"Toubiana","year":"2016","journal-title":"Blood"},{"key":"2021120808502254900_cei13192-bib-0017","doi-asserted-by":"crossref","first-page":"6558","DOI":"10.18632\/oncotarget.2289","article-title":"HDAC inhibitors and immunotherapy; a double edged sword?","volume":"5","author":"Kroesen","year":"2014","journal-title":"Oncotarget"},{"key":"2021120808502254900_cei13192-bib-0018","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/leu.2010.244","article-title":"HDAC inhibition by LBH589 affects the phenotype and function of human myeloid dendritic cells","volume":"25","author":"Song","year":"2011","journal-title":"Leukemia"},{"key":"2021120808502254900_cei13192-bib-0019","first-page":"2562","article-title":"Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice","volume":"118","author":"Reddy","year":"2008","journal-title":"J Clin Invest"},{"key":"2021120808502254900_cei13192-bib-0020","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.1128\/IAI.71.10.5690-5699.2003","article-title":"Deregulated production of protective cytokines in response to Candida albicans infection in patients with chronic mucocutaneous candidiasis","volume":"71","author":"Lilic","year":"2003","journal-title":"Infect Immun"},{"key":"2021120808502254900_cei13192-bib-0021","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/rheumatology\/kev022","article-title":"Inhibiting histone deacetylase 1 suppresses both inflammation and bone loss in arthritis","volume":"54","author":"Cantley","year":"2015","journal-title":"Rheumatology (Oxf)"},{"key":"2021120808502254900_cei13192-bib-0022","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1128\/AAC.01876-15","article-title":"Histone deacetylase inhibitors promote mitochondrial reactive oxygen species production and bacterial clearance by human macrophages","volume":"60","author":"Ariffin","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2021120808502254900_cei13192-bib-0023","doi-asserted-by":"crossref","first-page":"e02570","DOI":"10.1128\/AAC.02570-16","article-title":"Treatment with entinostat heals experimental cholera by affecting physical and chemical barrier functions of intestinal epithelia","volume":"61","author":"Sarker","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2021120808502254900_cei13192-bib-0024","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1101\/gr.168781.113","article-title":"Vascular histone deacetylation by pharmacological HDAC inhibition","volume":"24","author":"Rafehi","year":"2014","journal-title":"Genome Res"},{"key":"2021120808502254900_cei13192-bib-0025","doi-asserted-by":"crossref","first-page":"33274","DOI":"10.1038\/srep33274","article-title":"Entinostat up-regulates the CAMP gene encoding LL-37 via activation of STAT3 and HIF-1alpha transcription factors","volume":"6","author":"Miraglia","year":"2016","journal-title":"Sci Rep"},{"key":"2021120808502254900_cei13192-bib-0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cmi.12720","article-title":"Bacterial short-chain fatty acid metabolites modulate the inflammatory response against infectious bacteria","volume":"19","author":"Correa","year":"2017","journal-title":"Cell Microbiol"},{"key":"2021120808502254900_cei13192-bib-0027","doi-asserted-by":"crossref","first-page":"6237351","DOI":"10.1155\/2017\/6237351","article-title":"Proteomic analysis of HDAC3 selective inhibitor in the regulation of inflammatory response of primary microglia","volume":"2017","author":"Xia","year":"2017","journal-title":"Neural Plast"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.13192","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/194\/2\/205\/41646202\/cei13192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/194\/2\/205\/41646202\/cei13192.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:26:20Z","timestamp":1641054380000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/194\/2\/205\/6411886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,1]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,10,1]]},"published-print":{"date-parts":[[2018,10,19]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.13192","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,11]]},"published":{"date-parts":[[2018,10,1]]}}}